West Virginia MPJE (Pharmacy Jurisprudence) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the West Virginia MPJE Exam. Includes flashcards and multiple-choice questions, each with hints and explanations. Prepare effectively for your pharmacy law exam!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


Under the guidance of which law do generic drug manufacturers use the ANDA for approval?

  1. Biologics Control Act of 1902

  2. Drug Listing Act of 1972

  3. Hatch-Waxman Act (Price Competition and Patent Act) of 1984

  4. Prescription Drug Marketing Act of 1987

The correct answer is: Biologics Control Act of 1902

Generic drug manufacturers use the Abbreviated New Drug Application (ANDA) for approval under the guidance of the Hatch-Waxman Act (Price Competition and Patent Act) of 1984. This law created the ANDA pathway, which allows generic drug manufacturers to demonstrate bioequivalence to the reference listed drug without having to conduct extensive clinical trials. Therefore, the correct answer is C. The other options are incorrect: A. The Biologics Control Act of 1902 primarily focuses on regulating the production and sale of biological products. B. The Drug Listing Act of 1972 is intended to provide the FDA with a list of all drugs being manufactured, prepared, propagated, compounded, or processed by a drug manufacturer. D. The Prescription Drug Marketing Act of 1987 primarily addresses the distribution and wholesale marketing of prescription drugs to ensure their safety and effectiveness.